Literature DB >> 11580137

Regulation of biliary cholesterol secretion is independent of hepatocyte canalicular membrane lipid composition: a study in the diosgenin-fed rat model.

C P Nibbering1, A K Groen, R Ottenhoff, J F Brouwers, G P vanBerge-Henegouwen, K J van Erpecum.   

Abstract

BACKGROUND/AIMS: Phosphatidylcholine (PC) and sphingomyelin (SM) are the major phospholipids on the outer leaflet of the hepatocyte canalicular membrane. Since cholesterol preferentially associates with SM in detergent-resistant microdomains, we hypothesized that canalicular membrane lipid composition could modulate secretion of the sterol into bile.
METHODS: Male Wistar rats were fed for 10 days with a control diet with or without the plant sterol diosgenin (1% w/w) to induce biliary cholesterol hypersecretion. Thereafter, lipid compositions and phospholipid molecular species were determined in fistula bile and highly enriched canalicular membrane fractions.
RESULTS: Despite four-fold higher biliary cholesterol output in diosgenin-fed rats, no differences were observed between canalicular membranes of diosgenin and control groups with respect to cholesterol/phospholipid ratios (0.58 vs 0.62), phospholipid classes and acyl chain compositions of SMs (16:0 > 24:1 > 24:0 > 22:0 > 18:0 > 23:0 > 20:0 > 24:2), or PCs (mainly diacyl 16:0-18:2, 16:0-20:4, 18:0-20:4, and 18:0-18:2). In contrast to canalicular PCs, bile contained more hydrophilic species (mainly diacyl 16:0-18:2 and 16:0-20:4), without differences between both groups. In vitro resistance of purified canalicular membrane fractions against detergents such as Triton X-100 and taurocholate was also similar in both groups.
CONCLUSIONS: Diosgenin-induced biliary cholesterol hypersecretion occurs in the absence of changes of canalicular membrane lipids. Our data therefore do not support a major role of canalicular membrane lipid composition in regulation of biliary cholesterol secretion.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11580137     DOI: 10.1016/s0168-8278(01)00125-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  The mechanism of ABCG5/ABCG8 in biliary cholesterol secretion in mice.

Authors:  Astrid Kosters; Cindy Kunne; Norbert Looije; Shailendra B Patel; Ronald P J Oude Elferink; Albert K Groen
Journal:  J Lipid Res       Date:  2006-06-01       Impact factor: 5.922

2.  ABCG5/ABCG8-independent biliary cholesterol excretion in lactating rats.

Authors:  Donna J Coy; Clavia R Wooton-Kee; Baoxiang Yan; Nadezhda Sabeva; Kai Su; Gregory Graf; Mary Vore
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-22       Impact factor: 4.052

3.  Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.

Authors:  Martin Prescher; Sander H J Smits; Lutz Schmitt
Journal:  J Lipid Res       Date:  2020-09-11       Impact factor: 5.922

4.  Structures of ABCB4 provide insight into phosphatidylcholine translocation.

Authors:  Kamil Nosol; Rose Bang-Sørensen; Rossitza N Irobalieva; Satchal K Erramilli; Bruno Stieger; Anthony A Kossiakoff; Kaspar P Locher
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-17       Impact factor: 11.205

5.  Computer simulations suggest a key role of membranous nanodomains in biliary lipid secretion.

Authors:  Johannes Eckstein; Nikolaus Berndt; Hermann-Georg Holzhütter
Journal:  PLoS Comput Biol       Date:  2015-02-18       Impact factor: 4.475

6.  Cholesterol attenuates cytoprotective effects of phosphatidylcholine against bile salts.

Authors:  Yoshito Ikeda; Shin-Ya Morita; Tomohiro Terada
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

7.  The importance of membrane microdomains for bile salt-dependent biliary lipid secretion.

Authors:  Johannes Eckstein; Hermann-Georg Holzhütter; Nikolaus Berndt
Journal:  J Cell Sci       Date:  2018-03-01       Impact factor: 5.285

Review 8.  Diosgenin and Its Analogs: Potential Protective Agents Against Atherosclerosis.

Authors:  Dan Wang; Xiaolong Wang
Journal:  Drug Des Devel Ther       Date:  2022-07-17       Impact factor: 4.319

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.